Ranbaxy shares down on $500 mln fine to settle U.S. drug safety charges

Last Updated: Tue, May 14, 2013 05:07 hrs

Ranbaxy Laboratories Ltd shares were down over 1 percent in early trade on Tuesday after the generic drugmaker pleaded guilty to U.S. felony charges related to drug safety and will pay $500 million in civil and criminal fines.

The settlement is its largest-ever with a generic drugmaker over drug safety, according to the U.S. government.

More from Sify: